Overcoming barriers to monitoring patients taking second-generation antipsychotics

INTRODUCTION: Patients taking second-generation antipsychotics (SGAs) are at increased risk of developing metabolic syndrome because of the side effect profiles of these medications. A medication use evaluation (MUE) was conducted and showed that baseline monitoring rates of metabolic parameters in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ment Health Clin
Main Authors: Peña, Anita, DeJongh, Beth, Haas, Matthew, Harms, Michelle
Formato: Artigo
Idioma:Inglês
Publicado: College of Psychiatric & Neurologic Pharmacists 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007736/
https://ncbi.nlm.nih.gov/pubmed/29955545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2018.03.049
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares